{
  "id": "crc-biomarker",
  "display_name": "CRC Biomarker Testing",
  "cohort": "Colorectal Cancer, Biomarker Testing Compliance (2024–2025)",
  "insight_type": "Precision Medicine Utilization",
  "summary": "CRC biomarker testing averages 62% compliance, significantly below the 85% benchmark. Improving MSI/MMR, RAS/RAF and HER2 testing represents a $295,000 annual opportunity.",
  "chart": {
    "type": "bar",
    "unit": "biomarker",
    "data": [
      { "name": "MSI/MMR", "value": 78, "gap": -7, "highlight": false },
      { "name": "KRAS", "value": 82, "gap": -3, "highlight": false },
      { "name": "NRAS", "value": 64, "gap": -21, "highlight": true },
      { "name": "BRAF", "value": 58, "gap": -27, "highlight": true },
      { "name": "HER2", "value": 42, "gap": -43, "highlight": true },
      { "name": "NTRK", "value": 38, "gap": -47, "highlight": true }
    ],
    "benchmark": 85,
    "nccn_target": 95
  },
  "financial_impact": {
    "annual_opportunity": "$295,000/year",
    "math": "$295,000/year = 29% avg testing gap × 38 eligible patients × $26,800 precision therapy value"
  },
  "clinical_impact": {
    "description": "Comprehensive CRC biomarker testing improves treatment selection and patient outcomes.",
    "metrics": [
      {
        "type": "PFS",
        "value": "+5.8 months",
        "description": "Improved progression-free survival with matched therapies"
      },
      {
        "type": "OS",
        "value": "+9.4 months",
        "description": "Overall survival benefit with biomarker-guided treatment"
      },
      {
        "type": "ORR",
        "value": "+34%",
        "description": "Higher objective response rate with matched therapies"
      },
      {
        "type": "TRM",
        "value": "-58%",
        "description": "Reduced treatment-related mortality"
      },
      {
        "type": "QoL",
        "value": "+27%",
        "description": "Improved quality of life scores"
      }
    ],
    "quantitative": "+9.4 months OS"
  },
  "peer_comparison": {
    "description": "Top-performing CRC programs achieve >85% comprehensive biomarker testing compliance through reflex testing protocols.",
    "peer_benchmark": 85,
    "financial_impact": {
      "annual_opportunity": "$325,000/year",
      "math": "$325,000/year = 32% gap to peer benchmark × 40 patients × $25,400 improved care value"
    },
    "action_steps": [
      {
        "text": "Implement CRC-specific reflex molecular testing panel",
        "icon": "document"
      },
      {
        "text": "Create comprehensive testing protocol for all CRC patients",
        "icon": "clipboard"
      },
      {
        "text": "Develop automated biomarker tracking system",
        "icon": "chart"
      },
      {
        "text": "Establish CRC precision medicine tumor board",
        "icon": "users"
      }
    ]
  },
  "weighted_score": 93,
  "action_steps": [
    {
      "text": "Implement comprehensive NGS panel as standard for all mCRC",
      "icon": "document"
    },
    {
      "text": "Create provider education on emerging CRC biomarkers",
      "icon": "users"
    },
    {
      "text": "Develop universal MSI/MMR testing protocol at diagnosis",
      "icon": "clipboard"
    },
    {
      "text": "Establish biomarker testing KPI tracking by provider",
      "icon": "chart"
    }
  ],
  "suggestions": [
    {
      "text": "Consider tissue preservation protocol optimization",
      "icon": "clipboard"
    },
    {
      "text": "Evaluate HER2 testing implementation pathway",
      "icon": "search"
    }
  ],
  "drilldowns": [
    {
      "label": "By Provider",
      "cohort": "CRC Testing by Provider",
      "jsonFile": "crc-biomarker-by-provider.json",
      "drilldownLevel": 3
    },
    {
      "label": "By Testing Method",
      "cohort": "CRC Testing by Method",
      "jsonFile": "crc-biomarker-by-method.json",
      "drilldownLevel": 3
    },
    {
      "label": "All Biomarkers",
      "cohort": "Biomarker Testing by Cancer Type",
      "jsonFile": "biomarker-compliance-by-cancer.json",
      "drilldownLevel": 1
    },
    {
      "label": "Overall Compliance",
      "cohort": "Biomarker Testing Compliance",
      "jsonFile": "biomarker-compliance.json",
      "drilldownLevel": 0
    }
  ]
} 